Sartorius Stedim Biotech Balance Sheet Health
Financial Health criteria checks 3/6
Sartorius Stedim Biotech has a total shareholder equity of €3.9B and total debt of €3.1B, which brings its debt-to-equity ratio to 79.5%. Its total assets and total liabilities are €8.4B and €4.6B respectively. Sartorius Stedim Biotech's EBIT is €424.9M making its interest coverage ratio 3.1. It has cash and short-term investments of €695.1M.
Key information
79.5%
Debt to equity ratio
€3.07b
Debt
| Interest coverage ratio | 3.1x |
| Cash | €695.10m |
| Equity | €3.87b |
| Total liabilities | €4.57b |
| Total assets | €8.44b |
Recent financial health updates
Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet
May 13
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
Dec 01Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 23Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly
May 25Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly
Feb 07Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet
Nov 09Recent updates
Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet
May 13Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next
Apr 21With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For
Apr 20Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)
Feb 19Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear
Dec 22Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
Dec 01Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Nov 10Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 23Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly
May 25Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching
May 09Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Apr 23Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly
Feb 07Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?
Jan 20Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet
Nov 09Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today
Oct 20Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Oct 03We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt
Jul 26Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?
Jul 09Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 21Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt
Apr 21Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock
Apr 03We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit
Feb 24Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Dec 04Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt
Aug 21Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
May 10Financial Position Analysis
Short Term Liabilities: DIM's short term assets (€2.1B) exceed its short term liabilities (€975.4M).
Long Term Liabilities: DIM's short term assets (€2.1B) do not cover its long term liabilities (€3.6B).
Debt to Equity History and Analysis
Debt Level: DIM's net debt to equity ratio (61.5%) is considered high.
Reducing Debt: DIM's debt to equity ratio has increased from 8.7% to 79.5% over the past 5 years.
Debt Coverage: DIM's debt is well covered by operating cash flow (20.7%).
Interest Coverage: DIM's interest payments on its debt are well covered by EBIT (3.1x coverage).